Fineline Cube

Follow:
14499 Articles
GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation
CompanyDeals

GeneMind Biosciences Closes RMB 280 Million Series C+ Round to Fuel DNA Sequencer Innovation

Abbott Laboratories Receives FDA Approval for Tendyne TMVR System
CompanyMedical Device

Abbott Laboratories Receives FDA Approval for Tendyne TMVR System

AusperBio Secures $50M in Oversubscribed Series B+ Round to Advance Hepatitis B Therapy
CompanyDeals

AusperBio Secures $50M in Oversubscribed Series B+ Round to Advance Hepatitis B Therapy

BMS Gains European Approval for Opdivo Subcutaneous Formulation
CompanyDrug

BMS Gains European Approval for Opdivo Subcutaneous Formulation

Novartis' Fabhalta Approved for Previously Treated PNH Patients in China
CompanyDrug

Novartis’ Fabhalta Approved for Previously Treated PNH Patients in China

InnoCare Pharma Gains NMPA Clinical Approval for BCL2 Inhibitor ICP-248
CompanyDrug

InnoCare Pharma Gains NMPA Clinical Approval for BCL2 Inhibitor ICP-248

Fosun Pharma and Jiuyuan Gene Partner to Commercialize Biologics in Global Markets
CompanyDeals

Fosun Pharma and Jiuyuan Gene Partner to Commercialize Biologics in Global Markets

Lupeng Pharma's Rocbrutinib Near Approval for Mantle Cell Lymphoma
CompanyDrug

Lupeng Pharma’s Rocbrutinib Near Approval for Mantle Cell Lymphoma

Viva Biotech Establishes RMB 300M Fund for Early-Stage Pharma Projects
CompanyDeals

Viva Biotech Establishes RMB 300M Fund for Early-Stage Pharma Projects

Bayer's Sevabertinib Receives FDA Priority Review for HER2-mutant NSCLC
CompanyDrug

Bayer’s Sevabertinib Receives FDA Priority Review for HER2-mutant NSCLC

JW Therapeutics' Carteyva Receives Fourth sBLA for r/r LBCL
CompanyDrug

JW Therapeutics’ Carteyva Receives Fourth sBLA for r/r LBCL

Sino Medical Sciences Technology's AUCURA Flow-Diverting Stent Approved by NMPA
CompanyMedical Device

Sino Medical Sciences Technology’s AUCURA Flow-Diverting Stent Approved by NMPA